PREVENAR 13 (pneumococcal 13-valent conjugate vaccine - diphtheria CRM197 protein) Qualitative and Quantitative Composition

Medical Information
France
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you

This content is intended for French Healthcare Professionals. Would you like to proceed?

1 dose (0.5 ml) contains:

1
Conjugated to CRM197 carrier protein, adsorbed on aluminium phosphate.
Pneumococcal polysaccharide serotype 112.2 µg
Pneumococcal polysaccharide serotype 312.2 µg
Pneumococcal polysaccharide serotype 412.2 µg
Pneumococcal polysaccharide serotype 512.2 µg
Pneumococcal polysaccharide serotype 6A12.2 µg
Pneumococcal polysaccharide serotype 6B14.4 µg
Pneumococcal polysaccharide serotype 7F12.2 µg
Pneumococcal polysaccharide serotype 9V12.2 µg
Pneumococcal polysaccharide serotype 1412.2 µg
Pneumococcal polysaccharide serotype 18C12.2 µg
Pneumococcal polysaccharide serotype 19A12.2 µg
Pneumococcal polysaccharide serotype 19F12.2 µg
Pneumococcal polysaccharide serotype 23F12.2 µg

1 dose (0.5 ml) contains approximately 32 µg CRM197 carrier protein and 0.125 mg aluminium.

Excipients with known effect
For the full list of excipients, see section 6.1.